162 related articles for article (PubMed ID: 36513403)
1. Valproate, obesity and other causes of clozapine poor metabolism in the context of rapid titration may explain clozapine-induced myocarditis: A re-analysis of a Turkish case series.
Ertuğrul A; Anıl Yağcıoğlu AE; Ağaoğlu E; Karakaşlı AA; Ak S; Yazıcı MK; de Leon J
Rev Psiquiatr Salud Ment (Engl Ed); 2022; 15(4):281-286. PubMed ID: 36513403
[TBL] [Abstract][Full Text] [Related]
2. Four cases of myocarditis in US hospitals possibly associated with clozapine poor metabolism and a comparison with prior published cases.
Koenig M; McCollum B; Spivey JK; Coleman JK; Shelton C; Cotes RO; Goldsmith DR; De Leon J
Neuropsychopharmacol Hung; 2022 Mar; 24(1):29-41. PubMed ID: 35451590
[TBL] [Abstract][Full Text] [Related]
3. Should we routinely add CRP to clozapine titrations? - Learning from three cases.
Shelton C; Ruan CJ; Ertuğrul A; Cotes RO; De Leon J
Neuropsychopharmacol Hung; 2022 Dec; 24(4):153-161. PubMed ID: 36775960
[TBL] [Abstract][Full Text] [Related]
4. An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels.
de Leon J; Schoretsanitis G; Smith RL; Molden E; Solismaa A; Seppälä N; Kopeček M; Švancer P; Olmos I; Ricciardi C; Iglesias-Garcia C; Iglesias-Alonso A; Spina E; Ruan CJ; Wang CY; Wang G; Tang YL; Lin SK; Lane HY; Kim YS; Kim SH; Rajkumar AP; González-Esquivel DF; Jung-Cook H; Baptista T; Rohde C; Nielsen J; Verdoux H; Quiles C; Sanz EJ; De Las Cuevas C; Cohen D; Schulte PFJ; Ertuğrul A; Anıl Yağcıoğlu AE; Chopra N; McCollum B; Shelton C; Cotes RO; Kaithi AR; Kane JM; Farooq S; Ng CH; Bilbily J; Hiemke C; López-Jaramillo C; McGrane I; Lana F; Eap CB; Arrojo-Romero M; Rădulescu FŞ; Seifritz E; Every-Palmer S; Bousman CA; Bebawi E; Bhattacharya R; Kelly DL; Otsuka Y; Lazary J; Torres R; Yecora A; Motuca M; Chan SKW; Zolezzi M; Ouanes S; De Berardis D; Grover S; Procyshyn RM; Adebayo RA; Kirilochev OO; Soloviev A; Fountoulakis KN; Wilkowska A; Cubała WJ; Ayub M; Silva A; Bonelli RM; Villagrán-Moreno JM; Crespo-Facorro B; Temmingh H; Decloedt E; Pedro MR; Takeuchi H; Tsukahara M; Gründer G; Sagud M; Celofiga A; Ignjatovic Ristic D; Ortiz BB; Elkis H; Pacheco Palha AJ; LLerena A; Fernandez-Egea E; Siskind D; Weizman A; Masmoudi R; Mohd Saffian S; Leung JG; Buckley PF; Marder SR; Citrome L; Freudenreich O; Correll CU; Müller DJ
Pharmacopsychiatry; 2022 Mar; 55(2):73-86. PubMed ID: 34911124
[TBL] [Abstract][Full Text] [Related]
5. Clozapine-associated myocarditis in the World Health Organization's pharmacovigilance database: Focus on reports from various countries.
De Las Cuevas C; Sanz EJ; Ruan CJ; de Leon J
Rev Psiquiatr Salud Ment (Engl Ed); 2022; 15(4):238-250. PubMed ID: 36513400
[TBL] [Abstract][Full Text] [Related]
6. Clozapine-induced myocarditis may be associated with rapid titration: A case report verified with autopsy.
Chopra N; de Leon J
Int J Psychiatry Med; 2016; 51(1):104-15. PubMed ID: 26681239
[TBL] [Abstract][Full Text] [Related]
7. Clozapine-induced myocarditis during co-administration of valproate: A case report.
Jahołkowski P; Niewiadomska J; Wciórka J; Kowalski M; Świtaj P
Psychiatr Pol; 2019 Oct; 53(5):997-1002. PubMed ID: 31955181
[TBL] [Abstract][Full Text] [Related]
8. Effect of concomitant use of valproic acid during clozapine initiation on clozapine-induced inflammation among Japanese patients with schizophrenia.
Kikuchi Y; Komatsu H; Otsuka Y; Ito F; Yada Y; Tanifuji H; Tomita H
Psychiatry Res; 2024 Apr; 334():115810. PubMed ID: 38382186
[TBL] [Abstract][Full Text] [Related]
9. Rapid clozapine dose titration and concomitant sodium valproate increase the risk of myocarditis with clozapine: a case-control study.
Ronaldson KJ; Fitzgerald PB; Taylor AJ; Topliss DJ; Wolfe R; McNeil JJ
Schizophr Res; 2012 Nov; 141(2-3):173-8. PubMed ID: 23010488
[TBL] [Abstract][Full Text] [Related]
10. Reflections on the Complex History of the Concept of Clozapine-Induced Inflammation during Titration.
de Leon J
Psychiatr Danub; 2022; 34(3):411-421. PubMed ID: 36256975
[TBL] [Abstract][Full Text] [Related]
11. Can Slow Personalized Titration Using C-Reactive Protein Monitoring Decrease the High Rates and Mortality of Clozapine-Associated Myocarditis Seen in Some Countries? A Call for Research.
de Leon J
J Clin Psychopharmacol; 2024 May-Jun 01; 44(3):212-219. PubMed ID: 38595145
[TBL] [Abstract][Full Text] [Related]
12. Clozapine-associated myocarditis in the World Health Organization's pharmacovigilance database: Focus on reports from various countries.
De Las Cuevas C; Sanz EJ; Ruan CJ; de Leon J
Rev Psiquiatr Salud Ment (Engl Ed); 2021 Jul; ():. PubMed ID: 34298164
[TBL] [Abstract][Full Text] [Related]
13. Asymptomatic myocarditis during clozapine re-titration, in a patient who had previously been stable on clozapine for 10 years.
Smith LT; Symons E; Hare JL; Hooper M; Fitzgerald PB
Australas Psychiatry; 2014 Dec; 22(6):539-42. PubMed ID: 25313289
[TBL] [Abstract][Full Text] [Related]
14. Miocarditis inducida por clozapina durante la evaluación observacional, transversal y ongitudinal: comparación con otros antipsicóticos en ambientes naturalísticos.
Baptista T; Carrizo E; Rojas N; Fernández E; Velaz G; Servigna M; Serrano A; Sandia I; de Leon J; Pérez-Lopresti S
Invest Clin; 2016 Dec; 57(4):352-63. PubMed ID: 29938983
[TBL] [Abstract][Full Text] [Related]
15. A 12-month audit of clozapine associated myocarditis in a South Australian Local Health Network: The importance of screening and personalised titration.
Carswell O; Wilton LR; Nicholls K; Thomas V; Clark SR
Schizophr Res; 2024 Jun; 268():88-93. PubMed ID: 37722933
[TBL] [Abstract][Full Text] [Related]
16. Clinical course and analysis of ten fatal cases of clozapine-induced myocarditis and comparison with 66 surviving cases.
Ronaldson KJ; Fitzgerald PB; Taylor AJ; Topliss DJ; McNeil JJ
Schizophr Res; 2011 May; 128(1-3):161-5. PubMed ID: 21320766
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for clozapine-induced myocarditis and cardiomyopathy: A systematic review and meta-analysis.
Vickers M; Ramineni V; Malacova E; Eriksson L; McMahon K; Moudgil V; Scott J; Siskind D
Acta Psychiatr Scand; 2022 May; 145(5):442-455. PubMed ID: 35067911
[TBL] [Abstract][Full Text] [Related]
18. Association between myocarditis and antipsychotics other than clozapine: a systematic literature review and a pharmacovigilance study using VigiBase.
De Las Cuevas C; Sanz EJ; Rohde C; de Leon J
Expert Rev Clin Pharmacol; 2022 Jan; 15(1):65-78. PubMed ID: 35062840
[TBL] [Abstract][Full Text] [Related]
19. Clozapine metabolism and cardiotoxicity: A prospective longitudinal study.
Bellissima BL; Burns KE; Helsby NA; Kingston EL; Garavan F; Tingle MD
Int J Cardiol; 2024 May; 403():131788. PubMed ID: 38244893
[TBL] [Abstract][Full Text] [Related]
20. An international guideline with six personalised titration schedules for preventing myocarditis and pneumonia associated with clozapine.
de Leon J; Ruan CJ; Schoretsanitis G; Rohde C; Yağcıoğlu EA; Baptista T; Kirilochev OO; De Las Cuevas C; Correll CU
Gen Psychiatr; 2022; 35(3):e100773. PubMed ID: 35866000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]